Basilea Pharmaceutica AG/ CH0011432447 /
11/13/2024 5:19:30 PM | Chg. -0.30 | Volume | Bid5:20:00 PM | Ask5:20:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
40.80CHF | -0.73% | 3,481 Turnover: 142,259.60 |
-Bid Size: - | -Ask Size: - | 537.09 mill.CHF | - | 47.13 |
Assets
2014 US GAAP in mill. CHF |
2015 US GAAP in mill. CHF |
2016 US GAAP in mill. CHF |
2017 US GAAP in mill. CHF |
2018 US GAAP in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 12.2000 | 10.7000 | 8.9000 | 7.8000 | 6.4000 | ||||||
Intangible Assets | .2000 | .3000 | .2000 | .3000 | .4000 | ||||||
Long-Term Investments | 0.0000 | 0.0000 | 50 | 50 | 0.0000 | ||||||
Fixed Assets | 12.8000 | 13.9000 | 59.3000 | 58.2000 | 7 | ||||||
Inventories | 4.9000 | 9.6000 | 14.9000 | 15.3000 | 14.4000 | ||||||
Accounts Receivable | 1.2000 | 1.5000 | 2.5000 | 5 | 3.8000 | ||||||
Cash and Cash Equivalents | 156.1000 | 313.1000 | 239 | 200.7000 | 173 | ||||||
Current Assets | 244.6000 | 384.9000 | 268.5000 | 293 | 274.7000 | ||||||
Total Assets | 257.4000 | 398.7000 | 327.8000 | 351.2000 | 281.8000 |
Liabilities
2014 US GAAP in mill. CHF |
2015 US GAAP in mill. CHF |
2016 US GAAP in mill. CHF |
2017 US GAAP in mill. CHF |
2018 US GAAP in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 2.1000 | 1.1000 | 1.9000 | 4.4000 | 6.4000 | ||||||
Long-term debt | - | 194.7000 | 195.5000 | 196.2000 | 197 | ||||||
Liabilities to Banks | 0.0000 | 194.7000 | 195.5000 | 196.2000 | 197 | ||||||
Provisions | - | - | - | - | - | ||||||
Liabilities | 199.4000 | 383.9000 | 362.8000 | 392.6000 | 348.4000 | ||||||
Share Capital | - | - | - | - | - | ||||||
Total Equity | 57.9000 | 14.9000 | -35 | -41.4000 | -66.7000 | ||||||
Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Total liabilities equity | 257.4000 | 398.7000 | 327.8000 | 351.2000 | 281.8000 |
Income Statement
2014 US GAAP in mill. CHF |
2015 US GAAP in mill. CHF |
2016 US GAAP in mill. CHF |
2017 US GAAP in mill. CHF |
2018 US GAAP in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 42.6000 | 51.2000 | 66 | 101.5000 | 132.6000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -41.8000 | -61.5000 | -43.9000 | -14.1000 | -24.1000 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | -41.5000 | 61.5000 | -51 | -19 | -31.2000 | ||||||
Income Taxes | 0.0000 | -123.1000 | -.3000 | -.4000 | -.2000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Net Income | -41.5000 | -61.6000 | -51.3000 | -19.4000 | -31.4000 |
Per Share
Cash Flow
2014 US GAAP in mill. CHF |
2015 US GAAP in mill. CHF |
2016 US GAAP in mill. CHF |
2017 US GAAP in mill. CHF |
2018 US GAAP in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -71.5000 | -67.8000 | -75 | 19 | -79.2000 | ||||||
Cash Flow from Investing Activities | 83.7000 | 17.1000 | 1.2000 | -60.9000 | 59.4000 | ||||||
Cash Flow from Financing | 24.9000 | 208.1000 | .4000 | 2.6000 | -6 | ||||||
Decrease / Increase in Cash | 32.2000 | 156.9000 | -74 | -38.3000 | -26.8000 | ||||||
Employees | 230 | 250 | 240 | 230 | 227 |